Bolognani, Federico et al "RG1662, a Selective GABAA α5 Receptor Negative Allosteric Modulator, Increases Gamma Power in Young Adults with Down Syndrome. (P6.273)." Neurology 84.14 Supplement (2015): P6.273. Web. 03 June. 2023.